Taiwan Liposome Company, Ltd. American Depository Shares
TLC
TLC was delisted on the 28th of September, 2021.
5 hedge funds and large institutions have $3.81M invested in Taiwan Liposome Company, Ltd. American Depository Shares in 2018 Q4 according to their latest regulatory filings, with 5 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KPC
Karst Peak Capital
Hong Kong
|
+$3.38M |
| 2 |
Millennium Management
New York
|
+$650K |
| 3 |
Creative Planning
Overland Park,
Kansas
|
+$59.4K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$19.9K |
| 5 |
Morgan Stanley
New York
|
+$594 |
Top Sellers
TLC Hedge Fund Activity: Q4 2018 in Review
5 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in Taiwan Liposome Company, Ltd. American Depository Shares (TLC) for Q4 2018, worth a combined $3.81M.
Buyers outnumbered sellers: 5 funds opened new TLC positions and 0 closed out — a net gain of 5 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Karst Peak Capital, opening a new position worth an estimated $3.38M.
- 5 institutional investors held Taiwan Liposome Company, Ltd. American Depository Shares (TLC) as of Q4 2018, up from 0 in Q3 2018.
- Funds reported $3.81M of Taiwan Liposome Company, Ltd. American Depository Shares stock for Q4 2018.
- 5 funds opened new Taiwan Liposome Company, Ltd. American Depository Shares positions in Q4 2018 and 0 closed out, a net change of +5 holders.
- The largest Taiwan Liposome Company, Ltd. American Depository Shares buyer in Q4 2018 was Karst Peak Capital, an estimated $3.38M added.
Based on aggregated 13F filings for Q4 2018.